Roche Holding AG

Swiss Stock Exchange:RO.SW

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

🩺 Medical Instruments

💊 Pharmaceuticals

🔍 Research & Consulting

💉 Vaccines

Location

Switzerland

Market Cap

USD 243.15 B

Share Price

USD 317.50

Avg Daily Volume

25,392

Change (1 day)

-0.41%

Change (1 year)

-8.04%

Change (YTD)

6.11%

Roche Holding AG Enterprise Value to EBITDA (EV/EBITDA) on August 11, 2025: 14.70

Roche Holding AG Enterprise Value to EBITDA (EV/EBITDA) is 14.70 on August 11, 2025, a 6.45% change year over year. EV/EBITDA ratio compares the enterprise value to the EBITDA; lower suggests more favorable company valuation.

Roche Holding AG 52-week low Enterprise Value to EBITDA (EV/EBITDA) is 17.85 on August 11, 2025, which is 21.43% above the current Enterprise Value to EBITDA (EV/EBITDA).
Roche Holding AG 52-week low Enterprise Value to EBITDA (EV/EBITDA) is 12.10 on August 11, 2025, which is -17.68% below the current Enterprise Value to EBITDA (EV/EBITDA).
Roche Holding AG average Enterprise Value to EBITDA (EV/EBITDA) for the last 52 weeks is 14.47.